Back to Search
Start Over
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture.
- Source :
- Journal of Bone & Mineral Research; Jul2009, Vol. 24 Issue 7, p1308-1313, 6p, 4 Charts, 1 Graph
- Publication Year :
- 2009
-
Abstract
- The article discusses a study about the antifracture efficacy of zoledronic acid in relation to the timing of the administration of its first dose following hip fracture. It describes zoledronic acid as a potent biphosphonate which can prevent bone turnover markers as well as increase body mass index (BMD) when administered intravenously once a year. The study involved patients aged 50 years and above who were administered with the drug within 90 days after undergoing surgery for low-trauma hip fracture.
Details
- Language :
- English
- ISSN :
- 08840431
- Volume :
- 24
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Journal of Bone & Mineral Research
- Publication Type :
- Academic Journal
- Accession number :
- 42845348
- Full Text :
- https://doi.org/10.1359/JBMR.090209